FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas

Annals of Otology, Rhinology and Laryngology

Volumn 113, Issue 8, 2004, Pages 628-635

  Conessa, Claude ^a,b   Foehrenbach, Herve ^a,b   Hervé, Stephane ^a,b   Poncet, Jean Luc ^a,b  

^a Hôpital du Val de Grâce ^*

^b University of Paris Descartes   (France)

Author keywords

FDG PET scan; Head and neck carcinoma; Irradiation; Local follow up

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BIOPSY; CANCER CONTROL; CANCER RECURRENCE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; IRRADIATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 3543133723     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940411300806     Document Type: Article

References (30)

1. McGuirt WF, Greven K, Williams D III, et al. PET scanning in head and neck oncology: a review. Head Neck 1998; 20:208-15.
2. Fischbein NJ, AAssar OS, Caputo GR, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 1998;19:1189-96.
3. Som PM, Biller HF. Computed tomography of the neck in the postoperative patient: radical neck dissection and the myocutaneous flap. Radiology 1983;148:157-60.
4. Rugg T, Saunders MI, Dische S. Smoking and mucosal reactions to radiotherapy. Br J Radiol 1990;63:554-6.
5. Terhaard CH, Bongers V, van Rijk PP, Hordijk GJ. F-18-fluoro-deoxy- glucose positron emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 2001;23:933-41.
6. McGuirt WF, Greven KM, Keyes JW Jr, Williams DW III, Watson N. Laryngeal radionecrosis versus recurrent cancer: a clinical approach. Ann Otol Rhinol Laryngol 1998;107: 293-6.
7. Paulus P, Sambon A, Vivegnis D, et al. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 1998;108:1578-83.
8. Jabour BA, Choi Y, Hoh CK, et al. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993;186:27-35.
9. Keyes JW Jr, Watson NE Jr, Williams DW III, Greven KM, McGuirt WF. FDG PET in head and neck cancer. AJR Am J Roentgenol 1997;169:1663-9.
10. Foehrenbach H, Conessa C, Maszelin P, Kossowski M, Poncet JL, Gaillard JF. Tomographie par émission de positrons en oncologie de la tête et du cou. Ann Otolaryngol Chir Cervicofac 2001;118:365-72.
11. Ak I, Blokland JA, Pauwels EK, Stokkel MP. The clinical value of 18F-FDG detection with a dual-head coincidence camera: a review. Eur J Nucl Med 2001;28:763-78.
12. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro- D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135-41.
13. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-11.
14. Uematsu H, Sadato N, Yonekura Y, et al. Coregistration of FDG PET and MRI of the head and neck using normal distribution of FDG. J Nucl Med 1998;39:2121-27.
15. Hudgins PA, Burson JG, Gussack GS, Grist WJ. CT and MR appearance of recurrent malignant head and neck neoplasms after resection and flap reconstruction. AJNR Am J Neuroradiol 1994;15:1689-94.
16. Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and EORTC 1999 recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 1999;35:1773-82.
17. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000;30:150-85.
18. Rigo P, Paulus P, Kaschten BJ, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996;23:1641-74.
19. Warburg O, Wind F, Neglers E. On the metabolism of the tumors in the body. In: Warburg O, ed. Metabolism of tumors. London, England: Constable, 1930:254-70.
20. Peng NJ, Yen SH, Liu WS, Tsay DG, Liu RS. Evaluation of the effect of radiation therapy to nasopharyngeal carcinoma by positron emission tomography with 2-(F-18) fluoro-2-deoxy-D-glucose. Clin Positron Imaging 2000;3:51-6.
21. Cheon GJ, Chung JK, So Y, et al. Diagnostic accuracy of F-18 FDG-PET in the assessment of posttherapeutic recurrence of head and neck cancer. Clin Positron Imaging 1999;2:197-204.
22. Pai M, Park CH, Suh JH, Koh JH. Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer. Clin Nucl Med 1999;24:495-500.
23. Haenggeli CA, Dulguerov P, Slosman D, et al. Rôle de la tomographie par émission de positrons avec le 18-fluorodeoxyglucose (PET-FDG) dans la détection précoce d'une non-stérilisation tumorale des carcinomes bucco-pharyngo-laryngés. Schweiz Med Wochenschr Suppl 2000;116:8S-11S.
24. Farber LA, Bernard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy- D-glucose positron emission tomography. Laryngoscope 1999;109:970-5.
25. Chaiken L, Rege S, Hoh C, et al. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy. Int J Radiat Oncol Biol Phys 1993;27:455-64.
26. Kresnik E, Mikosch P, Gallowitsch HJ, et al. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 2001;28:816-21.
27. McGuirt WF, Greven KM, Keyes JW Jr, et al. Positron emission tomography in the evaluation of laryngeal carcinoma. Ann Otol Rhinol Laryngol 1995;104:274-8.
28. Conessa C, Clément P, Foehrenbach H, et al. Intérêt de la tomographie par émission de positrons dans le suivi postthérapeutique des carcinomes épidermoïdes de la tête et du cou. Rev Laryngol Otol Rhinol (Bord) 2001;122:253-8.
29. Greven KM, Williams DW III, Keyes JW Jr, et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 1994;74: 1355-9.
30. Stokkel MP, Terhaard CH, Hordjik GJ, van Rijk PP. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med 1999;26:767-73.